Emerging studies suggest Retatrutide , a dual stimulator targeting both GLP-1 and another hormone, may offer a promising step forward for body management . Initial clinical investigations have demonstrated substantial reductions in visceral mass , potentially outperforming existing obesity therapies . Despite this, further study is needed to ful… Read More